Table 2.
Groups | Baseline (T1), mean (SD) |
6 months (T2), mean (SD) |
9 months (T3), mean (SD) |
Within-group effect sizes (dz) |
Between-group effect sizes (ds) |
||||
T1-T2 | T1-T3 | T2a | T3b | ||||||
Depressive Symptoms (BDI-IAc) | |||||||||
|
CGd | 25.00 (8.65) | 13.62 (9.87) | 13.52 (11.49) | –1.03 | –0.95 | –0.10 | –0.05 | |
|
IGe | 27.27 (8.67) | 14.65 (11.36) | 14.07 (11.75) | –0.98 | –1.08 | |||
Quality of life (EuroQol/EQ-5D-3L) | |||||||||
|
CG | 8.25 (1.40) | 6.93 (1.80) | 6.95 (1.85) | –0.69 | –0.63 | –0.14 | –0.10 | |
|
IG | 8.61 (1.68) | 7.17 (1.63) | 7.12 (1.67) | -0.72 | –0.65 | |||
Quality of life (EQ VAS) | |||||||||
|
CG | 51.34 (17.69) | 69.16 (19.96) | 69.48 (21.34) | 0.60 | 0.76 | 0.16 | 0.10 | |
|
IG | 49.20 (16.61) | 65.92 (20.72) | 67.39 (21.74) | 0.75 |
0.74 |
aBetween-group effect sizes comparing CG versus IG at time 2 (T2).
bBetween-group effect sizes comparing CG versus IG at time 3 (T3).
cBDI-IA: Beck Depression Inventory-Spanish version.
dCG: control group (treatment as usual).
eIG: intervention group (ASCENSO + treatment as usual).